Glimepiride (oral)

DRUG2 trials

Sponsors

Intarcia Therapeutics, Tongji Hospital

Conditions

Chronic Heart Failure (CHF)Diabetes Mellitus, Type 2Type 2 Diabetes Mellitus (T2DM)

Phase 3

Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin

TerminatedNCT03060980

Intarcia TherapeuticsDiabetes Mellitus, Type 2

Start: 2017-03-03End: 2018-01-26Updated: 2019-03-07

Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.

Not yet recruitingNCT07288749

Tongji HospitalChronic Heart Failure (CHF), Type 2 Diabetes Mellitus (T2DM)

Start: 2026-01-01End: 2031-12-31Target: 1484Updated: 2025-12-17